Furthermore, CEBPB signaling has been shown to be activated in colorectal cancer cells following treatment with 5-FU (Wang et al., 2019), suggesting that CEBPB-mediated activation of DPYD expression might represent a dynamic response to therapy. Here, CEBPB is linked to colorectal cancer.